Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2

依托三酯 环氧合酶 药理学 化学 戊地昔布 美洛昔康 塞来昔布 全血 罗非昔布 生物化学 酶 医学 免疫学
作者
Denis Riendeau,M. David Percival,Christine Brideau,Stella E. Charleson,Daniel Dubé,Diane Ethier,Jean‐Pierre Falgueyret,Richard W. Friesen,Robert J. Gordon,Gillian M. Greig,Jocelyne Guay,Joseph A. Mancini,Marc Ouellet,Elizabeth Wong,Li Jing Xu,S. Boyce,Denise M. Visco,Yves Girard,Petpiboon Prasit,Robert J. Zamboni
出处
期刊:Journal of Pharmacology and Experimental Therapeutics [American Society for Pharmacology and Experimental Therapeutics]
卷期号:296 (2): 558-566 被引量:461
标识
DOI:10.1016/s0022-3565(24)38776-2
摘要

We report here the preclinical profile of etoricoxib (MK-0663) [5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl) pyridine], a novel orally active agent that selectively inhibits cyclooxygenase-2 (COX-2), that has been developed for high selectivity in vitro using whole blood assays and sensitive COX-1 enzyme assays at low substrate concentration. Etoricoxib selectively inhibited COX-2 in human whole blood assays in vitro, with an IC(50) value of 1.1 +/- 0.1 microM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC(50) value of 116 +/- 8 microM for COX-1 (serum thromboxane B2 generation after clotting of the blood). Using the ratio of IC(50) values (COX-1/COX-2), the selectivity ratio for the inhibition of COX-2 by etoricoxib in the human whole blood assay was 106, compared with values of 35, 30, 7.6, 7.3, 2.4, and 2.0 for rofecoxib, valdecoxib, celecoxib, nimesulide, etodolac, and meloxicam, respectively. Etoricoxib did not inhibit platelet or human recombinant COX-1 under most assay conditions (IC(50) > 100 microM). In a highly sensitive assay for COX-1 with U937 microsomes where the arachidonic acid concentration was lowered to 0.1 microM, IC(50) values of 12, 2, 0.25, and 0.05 microM were obtained for etoricoxib, rofecoxib, valdecoxib, and celecoxib, respectively. These differences in potency were in agreement with the dissociation constants (K(i)) for binding to COX-1 as estimated from an assay based on the ability of the compounds to delay the time-dependent inhibition by indomethacin. Etoricoxib was a potent inhibitor in models of carrageenan-induced paw edema (ID(50) = 0.64 mg/kg), carrageenan-induced paw hyperalgesia (ID(50) = 0.34 mg/kg), LPS-induced pyresis (ID(50) = 0.88 mg/kg), and adjuvant-induced arthritis (ID(50) = 0.6 mg/kg/day) in rats, without effects on gastrointestinal permeability up to a dose of 200 mg/kg/day for 10 days. In squirrel monkeys, etoricoxib reversed LPS-induced pyresis by 81% within 2 h of administration at a dose of 3 mg/kg and showed no effect in a fecal 51Cr excretion model of gastropathy at 100 mg/kg/day for 5 days, in contrast to lower doses of diclofenac or naproxen. In summary, etoricoxib represents a novel agent that selectively inhibits COX-2 with 106-fold selectivity in human whole blood assays in vitro and with the lowest potency of inhibition of COX-1 compared with other reported selective agents.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Alicyclobacillus完成签到,获得积分10
1秒前
我爱科研科研爱我完成签到,获得积分10
4秒前
5秒前
小蘑菇的应助被陈小黑采纳,获得10
5秒前
6秒前
ly完成签到,获得积分10
6秒前
7秒前
ref:rain完成签到 ,获得积分10
8秒前
杨淼发布了新的文献求助10
9秒前
饼大王完成签到,获得积分10
10秒前
11秒前
11秒前
一切顺利发布了新的文献求助10
11秒前
HY完成签到,获得积分10
11秒前
Gyqqqq发布了新的文献求助10
11秒前
inoo完成签到 ,获得积分10
12秒前
12秒前
13秒前
搜集达人的应助被xiang采纳,获得10
13秒前
wzy完成签到,获得积分10
14秒前
科目三的应助被明前易拉罐采纳,获得10
14秒前
MADAO发布了新的文献求助30
14秒前
15秒前
嗷嗷ao发布了新的文献求助10
15秒前
简单的浩然关注了科研通微信公众号
15秒前
哈哈嘿完成签到,获得积分10
16秒前
17秒前
千凡发布了新的文献求助10
18秒前
异乡人发布了新的文献求助10
18秒前
四月完成签到,获得积分10
18秒前
调皮的醉山完成签到 ,获得积分10
18秒前
18秒前
9527发布了新的文献求助10
19秒前
LL关闭了LL的文献求助
19秒前
一切顺利完成签到,获得积分10
20秒前
MARIO完成签到 ,获得积分10
20秒前
Chemistry完成签到,获得积分10
20秒前
chensiying完成签到 ,获得积分10
21秒前
21秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621